By the end of 2012, there were an estimated 2.1 million adolescents (aged 10–19 yrs) living with HIV; approximately two-thirds of new HIV infections in adolescents aged 15–19 years were among girls.1 We now have effective interventions to prevent new HIV infections and also to treat people living with HIV to ensure that they survive and thrive. Yet, because of their age, adolescents face specific barriers in accessing interventions because of factors that include community and service provider attitudes about adolescent sexual activity and government laws and policies that may prevent the majority of adolescents from independently seeking services and support. As a result, new infections, and late diagnosis and poor outcomes among adolescents living with HIV, are common.2
To substantially reduce the scale and impact of the AIDS epidemic, national AIDS responses must strengthen the quality and impact of programming for HIV prevention, treatment, and care for adolescents. To do this, program responses for adolescents must be more strategic. They must focus on interventions that are known to be effective and also address the underlying factors driving incidence and lack of effective treatment and care in this age group.
This article presents the results of a systematic review of systematic reviews examining the evidence on the effectiveness of selected HIV prevention, treatment, and care interventions among adolescents. We primarily focused on addressing the question of “Which interventions should be included in HIV programs targeting adolescents?” In addition, based on the available evidence, the review sought to answer the questions of how adolescents can be reached more effectively with impactful HIV interventions, how interventions can be delivered more successfully to adolescents, and how programs should be designed to ensure optimal HIV impact in adolescents? For example, how can a condom promotion and access program best be designed to ensure that the particular needs of adolescents are addressed to ensure they will have access to condoms?
The number of interventions among adolescents that might reduce HIV transmission risk, morbidity, and mortality is large. Intervention types included in this review were initially selected based on an a priori list of potential interventions. These were critically and iteratively reviewed, first by United Nations International Children's Emergency Fund (UNICEF) and then by panels of experts in adolescent research, programming, and policy at 2 technical meetings. The first meeting was held in April 2013 at the UNICEF Headquarters in New York. The second was a UNICEF meeting in London in July 2013. At each meeting, participants were asked to identify any known review articles of relevance, and these were also evaluated for inclusion in this review. Interventions have been divided into 2 categories as follows:
Interventions Primarily Designed for Adults
1. Voluntary medical male circumcision (VMMC),
2. Antiretrovirals (ARVs) for the prevention of mother-to-child transmission (PMTCT) of HIV,
3. HIV testing and counseling,
4. HIV treatment,
5. Condom use,
6. Provision of opioid substitution therapy to people who inject opioid drugs,
7. Provision of clean injecting equipment to people who inject drugs (PWID),
8. Oral preexposure prophylaxis (PrEP),
9. Topical PrEP (microbicides with antiviral activity against HIV) for the general population of women and for men who have sex with men (MSM),
10. Individual and group behavior change interventions among 3 key populations (MSM, PWID, and sex workers),
11. Sexually transmitted infection (STI) screening and treatment among 3 key populations (MSM, PWID, and sex workers), and
12. Mass media interventions.
The key questions in this category were whether these interventions can be effective, what characteristics make each intervention most effective, and what needs to be done differently to ensure that adolescents will also benefit from any prevention, treatment, care, and support interventions that were found to be effective among adults.
Interventions Specifically Designed for Adolescents and Young Adults
1. In-school HIV prevention education,
2. Delivery of services (eg, HIV testing, condoms) in youth centers,
3. Increasing adolescents' use of HIV prevention interventions (eg, HIV testing, condoms) by making health services more adolescent friendly (eg, increased privacy, youth-friendly hours, staff trained to work with adolescents),
4. School-based health services,
5. Community-wide interventions within geographically defined communities,
6. Conditional cash transfers (CCTs) to adolescents who stay in school,
7. CCTs to adolescents who remain STI free, and
8. Unconditional cash transfers (UCTs) to adolescents.
This category focused on specific interventions designed for adolescents and young adults aged 10–24 years. The key questions in this category were whether such interventions can be effective, and if so, how best to design and implement them for maximum effectiveness.
We conducted a systematic review of systematic reviews of interventions within these categories to evaluate the evidence of impact of each of these types of interventions on the key outcomes: HIV risk, HIV transmission, and HIV morbidity and mortality.3 Where these outcomes were not measured or where the evidence on effectiveness on these outcomes was not conclusive, we also considered evidence of impact on reported behavior change outcomes. For interventions specifically designed to target adolescents and young adults, a broader range of outcomes were included, as most evaluations of interventions targeting adolescents have not measured biological outcomes but have measured the impact on knowledge, self-reported sexual behavior, self-reported self-efficacy, and attitudes, or on uptake of health services. Furthermore, it is reasonable to expect that many of these interventions, on their own, would only improve these reported behavioral and knowledge outcomes, at least in the short term.
There are many types of HIV prevention interventions, which have not been evaluated in this report. We briefly present additional types of interventions and discuss the reasons for why they have not been reviewed in the Supplemental Digital Content (http://links.lww.com/QAI/A538).
For each intervention type, we conducted a search of the PubMed and Cochrane databases for systematic reviews of effectiveness published between January 2000 and April 30, 2013. The search was limited to English language review articles of studies in humans. Review articles which were based solely on mathematical modeling were excluded. Search terms used for each intervention type, the number of unique citations found, and the number of citations selected for inclusion in this article are found in the Supplemental Digital Content (http://links.lww.com/QAI/A538). PubMed searches the title, abstract, key words, and MeSH terms (where indicated) of articles in its database. For recent publications in the last 1–2 years, MeSH terms may not yet have been applied. Therefore, for articles published between 2012 and 2013, we conducted an additional PubMed search where the word “review” was added to the search criteria.
The title and abstract of all citations identified were reviewed for relevance by 2 reviewers (E.L. and S.N.M.). Potentially relevant citations underwent full text review by 1 reviewer (S.N.M.) based on our predefined criteria for inclusion (Table 1). Any citation whose suitability for inclusion was unclear was reviewed by a second author (E.L.). A third reviewer (D.R.) was available in the event of a discrepant decision by the first 2 reviewers. We also conducted a hand search of references of all the selected citations identified through the electronic searches to identify any additional relevant citations. Relevant data were then extracted systematically. Articles identified by expert panels at the technical meetings were also evaluated for inclusion in this review. Finally, where available, we also included information from unpublished systematic reviews and current recommendations conducted by the World Health Organization.
For interventions designed primarily for adults, we reviewed the most recent evidence first and worked in reverse chronological order. We selected one or more of the most recent, high-quality systematic reviews for inclusion, until we had high-quality evidence demonstrating that a type of intervention could be effective (as per our strength of evidence criteria, below) and/or was representative of the available evidence on the effectiveness of the intervention type. For interventions designed specifically for adolescents and young adults, all review citations that met our eligibility criteria were included.
Strength of Evidence
We used the evidence on the effectiveness of the specific intervention types as the basis for proposing recommendations on the key priority interventions for adolescent HIV programming. We developed a set of criteria for assessing the strength of the available evidence and evaluated each intervention type against these criteria. The assessment took into account the quantity of available evidence and quality of that evidence in terms of study design. This was assessed on a 3-level scale, denoted as A, B, or C, defined as follows:
A. High-quality evidence, defined as 3 or more experimental trials and/or high-quality quasi-experimental studies, or at least one meta-analysis of such studies, coupled with evidence from observational studies.
B. Moderate-quality evidence, defined as 1–2 experimental trials and/or high-quality quasi-experimental studies, coupled with evidence from observational studies.
C. Low quality of evidence, defined as observational data only, or only one moderate- or low-quality quasi-experimental study, coupled with evidence from observational studies.
We then looked at whether available evidence was in support of the intervention's efficacy. This was assessed on a 4-point scale:
1. All, or virtually all, studies showed statistically significant effectiveness.
2. Studies largely, but not consistently, showed significant effectiveness.
3. Mixed beneficial and ineffective or harmful results.
4. Consistently ineffective or harmful results.
The judgment of effectiveness was based on the statistical significance rather than on the absolute size of effect. Assessment of the quantity/quality of evidence and support for effectiveness were combined to give each intervention type a strength of evidence rating, with A1 being the strongest level of evidence of likely benefit and C4 the weakest. This strength of evidence rating then corresponded to the authors' recommendations, which were based solely on the evidence of effectiveness (Table 2). It is important to note that this methodology for assessing strength of evidence does not take account of the fact that different interventions will need different strengths of evidence to justify their implementation based on their feasibility, cost, potential size of benefit, risk of harm, acceptability, and other social or health benefits.4
Results and recommendations for each intervention type within each category are shown in Table 3 and Table 4. All citations that met our criteria for inclusion and any additional reviews or specific studies that informed our results are listed in the Supplemental Digital Content (http://links.lww.com/QAI/A538).
Interventions Primarily Designed for Adults
TABLE 3-b Summary of...Image Tools
TABLE 3-c Summary of...Image Tools
For many of the preselected interventions primarily designed for adults, there was strong evidence of a significant impact on HIV incidence. Based on the data from randomized controlled trials (RCTs) conducted in the general population of men living in high HIV-burden countries in sub-Saharan Africa, VMMC significantly decreased HIV incidence.5–9 However, data on the impact of male circumcision among MSM came entirely from observational studies. Whereas there was evidence for a protective effect of male circumcision among those MSM who reported an insertive role, there was no evidence of protection among those reporting a receptive role.5–9 ARVs for PMTCT of HIV,10,11 HIV treatment,15 and condom use18 were also found to have a significant impact on HIV incidence. There was also strong evidence that highly active ARV treatment has a significant impact on HIV disease progression.15 A systematic review was not conducted of the independent effects on HIV acquisition or onward transmission of HIV testing and counseling among adults as there is no other way for HIV-positive individuals to be identified. This intervention has therefore been recommended as the essential entry point to treatment, care, and support rather than as a potential HIV prevention intervention in its own right. Additionally, there was strong evidence that the provision of opioid substitution therapy to PWID had a significant impact on HIV incidence.20,21 The evidence supporting the impact of provision of clean injecting equipment to PWID on reduction of self-reported risky injecting behavior was strong but the evidence was less strong, and there was some inconsistency in the evidence for a reduction in HIV incidence.24,25 On the other hand, the more tentative findings related to the impact on HIV incidence may reflect a lack of rigorous studies of this intervention that included a biological HIV end point.
For other intervention types within this category, the evidence supporting an impact on our key HIV outcomes was less strong. In terms of ARV for oral PrEP, although 3 early well-conducted RCTs among heterosexual couples and MSM demonstrated a significant reduction in incident HIV with both tenofovir disoproxil fumarate and tenofovir disoproxil fumarate plus emtricitabine oral PrEP, 2 recent trials of these interventions among women were either stopped for futility or showed no effect.26 Preliminary evidence suggests that the lack of effect in these 2 trials was probably due to low adherence, suggesting that adherence will be a key challenge in PrEP implementation. Though review articles were not available, 1 RCT of oral PrEP in adults who inject drugs28 showed a reduction in HIV incidence. Specific evidence on the effectiveness of oral PrEP among sex workers was unavailable. Evidence on the effectiveness of topical PrEP in a general population of women demonstrated a significant reduction in HIV incidence when PrEP was administered pericoitally, though not when administered daily.29,30 Evidence related to daily administration of topical PrEP again suggests that the lack of effectiveness was related to low adherence to this regimen. Systematic reviews of topical PrEP among MSM were unavailable.
Behavior change interventions among PWID have demonstrated effectiveness in reducing self-reported risk behaviors, with some evidence indicating the potential to affect HIV incidence.31 Specific promising interventions among this population included HIV testing and result disclosure, individual-level behavioral interventions, behavior change interventions with HIV-discordant couples, network- or peer-based interventions, provision of injecting equipment, condom provision, opioid substitution therapy, STI treatment, and antiretroviral therapy. Similarly, there is evidence that behavior change interventions among MSM have the potential to effectively reduce self-reported unprotected anal intercourse, though there was no evidence of a significant impact on HIV incidence.32,33 Group- and community-level interventions seemed to be more effective than individual-level interventions. There was a small amount of evidence, which indicated that individualized risk reduction counseling or community-level interventions may be effective in reducing reported risky behavior among adolescent MSM. In low-income countries, there was strong evidence that behavior change interventions among sex workers can effectively reduce incident STIs and promote reported behavior change, including increased self-reported condom use and a reduction in use of psychoactive drugs.40–42 Effective strategies included social, cognitive, and behavioral interventions, the promotion and increased availability of condoms through outreach, peer promotion and risk counseling, and outreach by health workers. Structural interventions, such as microenterprise support for sex workers, also demonstrated success in increasing self-reported condom use.
There was evidence from high-income countries that interventions to increase HIV and STI screening and treatment for STIs among MSM could effectively increase uptake of HIV testing.45–47 Available data did not identify clear characteristics of effective HIV screening and treatment interventions among MSM, other than the utilization of the now-standard point-of-care rapid testing (as opposed to remote testing in a laboratory) and opt-out, rather than opt-in, HIV testing strategies.
Finally, there was evidence that mass media interventions were a promising approach to increasing uptake of HIV testing in adults.48–50 The use of multiple media channels, such as a combination of television, radio, and print material, appeared to be most effective.
Overall, evidence from systematic reviews for how adolescents can best access the most promising of interventions primarily designed for adults was modest, at best. Few systematic reviews of evidence of this nature were identified, with limited additional evidence available from other reviews that did not meet our criteria for inclusion for several other intervention types. For adolescents' access to HIV testing and counseling, there was evidence that they face unique barriers to access, at least in some contexts.13 Interventions may therefore require tailored support, such as targeted out-of-facility services (eg, mobile clinics, street- and youth center–based services, home-based testing), opt-out provider-initiated testing and counseling, the use of rapid testing, and provision of testing within a setting providing adolescent-friendly health services.13,14 Regarding interventions to increase HIV treatment access among adolescents, there were data indicating that, when compared with North Americans and Europeans, African children and adolescents starting treatment tended to be older and at more advanced levels of immunosuppression.16,17 This suggests that they face greater barriers to diagnosis and/or treatment. However, the same is also true for adults.75 Community-based condom distribution strategies (eg, street outreach, peer distribution) may increase access to condoms among adolescents, and combination of specific condom promotion interventions with other interventions, such as education and training related to communication and decision-making skills, also showed potential for increasing condom use among adolescents.14,19 Regarding provision of opioid substitution therapy to adolescents who inject drugs, the strongest evidence of effectiveness for this reducing HIV incidence is for methadone replacement therapy, and there were clear legal obstacles to adolescents in the United States accessing methadone replacement therapy.23 Mass media interventions showed potential to be effective for improving several outcomes among adolescents, including HIV prevalence, through the use of interventions combining television and radio with supporting material.51 New technologies are also being used for mass media interventions, including using cellular communication, social media, and mobile health products to reach participants. They represent innovative new platforms for delivering interventions.
Interventions Specifically Designed to Target Adolescents and Young Adults
The interventions in this second category, by their very nature, were designed specifically for an adolescent population. With the exception of in-school interventions, there were few reviews of the interventions in this category that met our criteria for inclusion. In-school interventions remain an efficient means of targeting school-going adolescents, and several such interventions have been demonstrated to be effective in improving knowledge, reported attitudes, and skills.52–69 However, the few trials that have evaluated their impact on biological outcomes have largely found no significant effects on outcomes, such as HIV incidence, STI prevalence, or pregnancy rates, despite showing some evidence of positive self-reported behavior change, though the latter have not been universal for all risk behaviors studied. These apparently inconsistent results may reflect either relatively small, but sometimes statistically significant, absolute effects on true sexual risk behaviors or differential desirability bias in reporting sexual behaviors by trial arm. Delivery of interventions by trained adult facilitators, having multiple session programs, curricula that include skills and knowledge-building activities, and programs that are specifically designed or adapted for the local context were key characteristics of the more successful interventions.57,61,62,65,69 Evidence suggested that most abstinence-only and peer-led in-school interventions were not effective.
We did not find evidence that youth centers, ie, youth-specific venues where young people can access information and services which address their needs and wants, were an effective or cost-effective method of increasing use of clinical sexual and reproductive health services. Although they were primarily accessed by males for recreational services, females were the primary users of the sexual and reproductive health services they provided, and overall, the number of unique clinic users was usually so low that the services were not cost-effective.70
Making health services more adolescent friendly by rigorous implementation of interventions, including training of service providers, outreach activities, and out-of-facility services tailored to context and target population, demonstrated some impact on uptake of health services.14,53,62,66,76,77 Studies have indicated that a significant proportion of adolescents remained underserved by school-based health services, and therefore, they should be used to complement, not replace, health-care services for adolescents located outside schools.71,72
There was some evidence that community-level interventions have the potential to affect HIV prevalence and herpes simplex virus type-2 (HSV-2) incidence.57,78,79 Specific characteristics of effective interventions included those that specifically target adolescents and create their own system or structure for intervention delivery.
Overall, data on the impact of cash transfers on HIV-related outcomes were limited but promising. Trials of CCTs to stay in school showed some evidence of an impact on biological outcomes, including HIV incidence and HSV-2 prevalence.73 These results are likely to only be effective in settings where there are significant financial barriers to school attendance and where being in school is protective against HIV. There were 2 reviews identified on the effectiveness of cash transfers conditioned on staying STI free, both reporting on the same 2 trials.73,74 Neither study specifically focused on young people, however. Whereas 1 trial in Tanzania reported a significant impact on STI incidence, a Malawi trial found no significant impact on HIV incidence and mixed effects on self-reported sexual risk behaviors. There was also a small amount of evidence suggesting that UCTs can decrease school dropout rates, by addressing structural barriers which increase adolescent risk of HIV.73 Generally, smaller payments made more frequently and closer to the behavior being observed were more effective than the promise of larger payments in the future.
A summary of the recommendations from this review is found in Table 5, and the intervention types are presented by strength of evidence rating in Table 6. Importantly, recommendations from this review are based solely on the available evidence on effectiveness and do not take into consideration other important factors, such as feasibility, cost, potential size of benefit, risk of harm, acceptability, and other social or health benefits.80 At least 2 additional factors will need to be considered when making policy decisions about what interventions to prioritize among adolescents. First, for interventions that are designed primarily to target adults, the current uptake of each intervention among adolescents and how this compares with coverage among adults will be important for prioritizing specific interventions to ensure adolescents' access to interventions that are of known effectiveness among adults. Second, we did not review intervention costs, where they have been reported. Estimates of the costs of each of the interventions will be important for the allocation of available funding.
Adolescence is a period of major transitions, particularly in terms of sexual and reproductive health needs. Interventions that are appropriate for older adolescents may not be relevant or appropriate for younger adolescents. In addition to sexual orientation and gender, interventions should be tailored to the specific populations targeted, taking into account, for example, whether youth are attending school, whether they are married, and other variables. Although we set out to disaggregate the results based on criteria, such as age, marital status, and whether the adolescent was still in formal education, the data were not usually reported by such subgroups in the review articles included in this report.
Certain types of interventions in this review have considerable amounts of evidence and/or evidence of high quality, whereas other interventions have very little evidence in terms of their effectiveness on HIV-related outcomes and/or only have evidence of relatively low quality. In some cases, this may be because of the limited effectiveness having been found within the initial intervention studies and thus little impetus to conduct additional and higher quality research. However, in other instances, this may not be a reflection of the potential of the intervention but rather the barriers to conducting high-quality interventions, in terms of logistics and/or resources. Such studies are particularly problematic among adolescents, for several reasons. First, the incidence of HIV among young adolescents is generally relatively low so population-based studies need to be very large. Studies of adolescents below the age of 18 years (or even older in some countries) are also complicated by additional parental informed consent requirements, especially if they include collection of biological specimens. Finally, if an intervention type is relatively new, sufficient studies may not have yet been conducted to have resulted in the publication of a systematic review. This review was not able to distinguish between these various possibilities but rather was designed to present the current state of the published evidence.
A major constraint on this review was that, with the exception of a few intervention types, there was a dearth of systematic review data on how best to enable adolescents to access the intervention types that were identified as having proven effective among adults. There is a clear need for more rigorous research in this area.
Strengths and Limitations
This review provides an important summary of the existing evidence on the effectiveness of a wide range of different types of interventions. We employed a systematic review of systematic reviews methodology24,33,81 to consolidate and summarize the data on the effectiveness of a total of 20 intervention types, to identify key characteristics of effective interventions, and to explore the evidence from systematic reviews of how adolescents can best access those interventions with proven effectiveness. This approach allowed us to rigorously and systematically review a large number of intervention types in 1 document using a standard transparent methodology. We developed criteria for assessing the strength of the available evidence on effectiveness, which was systematically applied to each intervention type and used to develop author recommendations for what intervention types are most promising to consider for adolescent HIV programming in terms of their evidence of effectiveness. Methodological limitations are inherent in this strategy. In using only review articles rather than primary data, we relied on the data and focus presented by the review authors. There is likely to have been heterogeneity of interventions, outcomes, and study designs. Furthermore, the reports of the studies had already been summarized; so, the information will have been less detailed than in the primary study reports, resulting in the potential for exclusion of more nuanced descriptions of characteristics of interventions important to their effectiveness or lack thereof. In addition, by only searching for review articles, we may have missed effective interventions that have been evaluated but have not yet been included in a published systematic review. Nonetheless, systematic review of systematic reviews is a useful strategy that has been proposed by the UK Health Development Agency81 and employed in numerous previous peer-reviewed articles.24,33 We reviewed a very large number of interventions, and a systematic review of systematic reviews was employed for practical reasons and also because, for most intervention types, high-quality reviews could be identified that adequately summarized the available data. Our review did highlight an absence of systematic reviews of some intervention types, which is likely to reflect the lack of published primary data, at least up to the recent past.
Another methodological limitation is that we limited our search to just 2 databases, PubMed and Cochrane; therefore, there is the possibility that we did not identify all high-quality systematic reviews. However, with the large volume of citations included in these databases, we feel it is unlikely that we overlooked any high-quality reviews that would have substantively altered the results presented here. We also did not systematically search the gray literature. After reviewing our results, expert consultants in adolescent HIV research and programming were asked to inform us of any other review articles of relevance, and these were included when they met the inclusion criteria. We also summarized unpublished systematic reviews conducted for the World Health Organization related to recent global or regional HIV guidelines and referred to these guidelines where available. For interventions specifically designed to target adolescents and young adults, we systematically reviewed all review articles that met our criteria for inclusion, but for the interventions primarily designed for adults, we selected the most recent, high-quality systematic reviews for inclusion that adequately summarized the available data from all the citations identified. In doing so, we may have overlooked important reviews that were published less recently.
We limited the review to the impact of interventions on biological HIV-related outcomes. Where such evidence was not available, or did not strongly support the intervention type, we looked beyond our 3 key outcomes to capture data on reported behavior change. For interventions that target adolescents, we also incorporated data on the impact on knowledge and reported attitudes. Some interventions may have effects on other outcomes, which are not directly HIV related but may be potential structural or other indirect determinants of HIV acquisition risk, such as poverty or employment, which we will not have captured yet may be extremely important. For example, cash transfers conditioned on adolescent girls remaining in, or returning to, school may have important effects on educational attainment, earning potential, desirability as a potential spouse, subsequent mothering skills, other health outcomes for themselves and their future families, and so on.
We developed a methodology to assess the strength of evidence available for each intervention type and to generate recommendations. It is relatively simple to use, can be applied across multiple intervention types, and indicates the weights assigned to the evidence on each intervention type. However, this methodology has limitations. First, although an experimental study is considered the strongest form of evidence, for ethical or other reasons, the comparison arm in an experimental study may not always have been the complete absence of any intervention but rather the current standard of care. In such cases, the measured effectiveness would likely be less than if the intervention had been evaluated against no intervention. Second, this methodology does not explicitly take account of geographical representativeness of the existing studies or their likely generalizability. Lastly, the methodology does not take account of the fact that different interventions will need different strengths of evidence to justify implementation based on their feasibility, cost, potential size of benefit, risk of harm, acceptability, and other social or health benefits.4 Evaluation of these factors was beyond the scope of this review and will need to be done as a separate exercise before decisions are made about the relative priority to be given to each intervention type.
Also worth noting is that this review attempted to examine individual intervention types but did not look at combinations of interventions. Integrated programs with multiple, linked synergistic interventions may be more effective than any single intervention. Programs such as MEMA kwa Vijana in Tanzania82–84 and Regai Dzive Shiri in Zimbabwe85,86 are examples of combination interventions targeting adolescents, and several large rigorous evaluations of combination HIV interventions are currently in progress, such as the Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART) trial in Zambia and South Africa, which includes young adults, but not adolescents.87
From our systematic review of systematic reviews, we identified a number of interventions that showed strong promise of effectiveness (Tables 5 and 6). Of the interventions designed specifically for adolescents, there was high-quality evidence which indicated that, if they include identified key characteristics, in-school interventions and interventions in geographically defined communities can have a positive impact on a number of important HIV outcomes. Based on these results, it is recommended that these interventions should be considered for wide-scale implementation. Additionally, there is promising evidence that some cash transfer interventions can positively affect HIV outcomes in adolescents, though additional results from a number of ongoing trials and careful consideration of cost-effectiveness and sustainability are required before these can be recommended for scale-up. As health services are a gateway to a number of other effective interventions, including antiretroviral therapy, PMTCT, treatment as prevention strategies, STI treatment, and provision of condoms, resources should be allocated toward the development and implementation of interventions to increase health service use among adolescents and young people, including making them more adolescent friendly. Few other interventions in this category can be recommended for scale-up, due to weak evidence of effectiveness, evidence for an impact on self-reported behavior only, or there having been too few rigorous intervention studies.2,12,22,27,34–39,43,44,79
A number of interventions designed primarily for adults have high-quality evidence of potential efficacy: VMMC, ARVs for PMTCT, HIV testing and counseling, HIV treatment, condom use, and provision of sterile injecting equipment to PWID. There was also evidence of potential efficacy for oral PrEP among heterosexual couples and MSM and behavior change interventions among PWID and MSM. These should be priority interventions, which should be included in all HIV prevention programming for adolescents. A key public health question is “What does it take to reach adolescents more effectively with these high-impact interventions?” However, with only a few notable exceptions, there was a dearth of rigorous reviews of their current uptake by adolescents relative to older age groups and of what should be done differently to enable adolescents to access these interventions at least as much as adults. While there may have been primary studies addressing this question, the lack of systematic reviews indicates that inadequate attention has been paid to adolescent access to effective HIV prevention, treatment, and care strategies. We recommend that the generation of such evidence through operations research, and age and sex disaggregation of programmatic and research study coverage and utilization data, be an urgent research priority, with rigorous studies focusing on those interventions of proven efficacy identified here.
The authors thank Susan Kasedde, Ken Legins, Craig McClure, Rachel Yates, Chewe Luo, and Upjeet Chandan of UNICEF for advice and critical review of an earlier draft of this report. The authors also thank participants of the April 2013 meeting at UNICEF Headquarters in New York and of the July 2013 UNICEF meeting in London for their comments and suggestions. The authors thank Harriet Hallas and Claudia DaSilva of the Infectious Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, for administrative support.
1. United Nations Children's Fund. Towards an AIDS-Free Generation—Children and AIDS: Sixth Stocktaking Report 2013. New York, NY: United Nations Children's Fund; 2013.
2. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2013.
3. Schwartlander B, Stover J, Hallett T, et al.. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377:2031–2041.
4. Ross DA, Dick B, Ferguson J. Preventing HIV/AIDS in young people. A systematic review of the evidence from developing countries. World Health Organ Tech Rep Ser. 2006;938.
5. Byakika-Tusiime J. Circumcision and HIV infection: assessment of causality. AIDS Behav. 2008;12:835–841.
6. Krieger JN. Male circumcision and HIV infection risk. World J Urol. 2012;30:3–13.
7. Perera CL, Bridgewater FH, Thavaneswaran P, et al.. Safety and efficacy of nontherapeutic male circumcision: a systematic review. Ann Fam Med. 2010;8:64–72.
8. Siegfried N, Muller M, Deeks JJ, et al.. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009.
9. Wiysonge CS, Kongnyuy EJ, Shey M, et al.. Male circumcision for prevention of homosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2011.
10. Siegfried N, van der Merwe L, Brocklehurst P, et al.. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011;CD003510.
11. Suksomboon N, Poolsup N, Ket-Aim S. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J Clin Pharm Ther. 2007;32:293–311.
12. WHO, UNODC, UNAIDS. Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users—2012 Revision. Geneva, Switzerland: WHO, UNODC and UNAIDS; 2012.
13. Committee on Pediatric Aids; Emmanuel PJ, Martinez J. Adolescents and HIV infection: the pediatrician's role in promoting routine testing. Pediatrics. 2011;128:1023–1029.
14. Denno DM, Chandra-Mouli V, Osman M. Reaching youth with out-of-facility HIV and reproductive health services: a systematic review. J Adolesc Health. 2012;51:106–121.
15. Jordan R, Gold L, Cummins C, et al.. Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. BMJ. 2002;324:757.
16. Sutcliffe CG, van Dijk JH, Bolton C, et al.. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477–489.
17. Kahana SY, Rohan J, Allison S, et al.. A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults. AIDS Behav. 2013;17:41–60.
18. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med. 1993;36:1635–1644.
19. Foss AM, Hossain M, Vickerman PT, et al.. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia. Sex Transm Infect. 2007;83:510–516.
20. MacArthur GJ, Minozzi S, Martin N, et al.. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.
21. Gowing L, Farrell MF, Bornemann R, et al.. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;CD004145.
22. WHO. Guidance on Pre-exposure Oral Prophylaxis (PrEP) for Serodiscordant Couples, Men and Transgender Women Who Have Sex with Men at High Risk of HIV: Recommendations for Use in the Context of Demonstration Projects. Geneva, Switzerland: WHO; 2012.
23. Subramaniam GA, Fishman MJ, Woody G. Treatment of opioid-dependent adolescents and young adults with buprenorphine. Curr Psychiatry Rep. 2009;11:360–363.
24. Palmateer N, Kimber J, Hickman M, et al.. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105:844–859.
25. Des Jarlais DC, Feelemyer JP, Modi SN, et al.. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health. 2013;13:53.
26. Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;7:CD007189.
27. WHO, UNAIDS, UNICEF. Guidelines: Prevention and Treatment of HIV and Other Sexually Transmitted Infections Among Men Who Have Sex with Men and Transgender People: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2011.
28. Choopanya K, Martin M, Suntharasamai P, et al.. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083–2090.
29. Obiero J, Mwethera PG, Wiysonge CS. Topical microbicides for prevention of sexually transmitted infections. Cochrane Database Syst Rev. 2012;6:CD007961.
30. Obiero J, Mwethera PG, Hussey GD, et al.. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis. 2012;12:289.
31. Degenhardt L, Mathers B, Vickerman P, et al.. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285–301.
32. Sullivan PS, Carballo-Dieguez A, Coates T, et al.. Successes and challenges of HIV prevention in men who have sex with men. Lancet. 2012;380:388–399.
33. Lorimer K, Kidd L, Lawrence M, et al.. Systematic review of reviews of behavioural HIV prevention interventions among men who have sex with men. AIDS Care. 2013;25:133–150.
34. Mustanski B. Ethical and regulatory issues with conducting sexuality research with LGBT adolescents: a call to action for a scientifically informed approach. Arch Sex Behav. 2011;40:673–686.
35. Idele P. Overview of adolescents and HIV and AIDS: prevalence, knowledge, behaviour and access to HIV services. Paper presented at: Global Technical Meeting: Operationalizing an Investment Approach for Improved Results in HIV Prevention, Treatment and Care in Adolescents. London, United Kingdom; July 8-10, 2013.
36. Hays RB, Rebchook GM, Kegeles SM. The Mpowerment Project: community-building with young gay and bisexual men to prevent HIV1. Am J Community Psychol. 2003;31:301–312.
37. Rebchook GM, Kegeles SM, Huebner D, et al.. Translating research into practice: the dissemination and initial implementation of an evidence-based HIV prevention program. AIDS Educ Prev. 2006;18(4 suppl A):119–136.
38. WHO, UNAIDS, UNICEF. Prevention and Treatment of HIV and Other Sexually Transmitted Infections for Sex Workers in Low- and Middle-income Countries: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO, UNAIDS, UNICEF; 2012.
39. Hoffmann O, Boler T, Dick B. Achieving the global goals on HIV among young people most at risk in developing countries: young sex workers, injecting drug users and men who have sex with men. World Health Organ Tech Rep Ser. 2006;938:287–315; discussion 7–41.
40. Wariki WM, Ota E, Mori R, et al.. Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low- and middle-income countries. Cochrane Database Syst Rev. 2012;2:CD005272.
41. Ota E, Wariki WM, Mori R, et al.. Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high-income countries. Cochrane Database Syst Rev. 2011;CD006045.
42. Chersich MF, Luchters S, Ntaganira I, et al.. Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services. J Int AIDS Soc. 2013;16:17980.
43. WHO. Preventing HIV in Sex Work Settings in Sub Saharan Africa. Geneva, Switzerland: World Health Organization; 2011.
44. Steen R, Dallabetta G. Sexually transmitted infection control with sex workers: regular screening and presumptive treatment augment efforts to reduce risk and vulnerability. Reprod Health Matters. 2003;11:74–90.
45. Wei C, Herrick A, Raymond HF, et al.. Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women. Cochrane Database Syst Rev. 2011;CD009337.
46. Thornton AC, Delpech V, Kall MM, et al.. HIV testing in community settings in resource-rich countries: a systematic review of the evidence. HIV Med. 2012;13:416–426.
47. Lorenc T, Marrero-Guillamon I, Aggleton P, et al.. Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness. Sex Transm Infect. 2011;87:272–278.
48. Noar SM, Palmgreen P, Chabot M, et al.. A 10-year systematic review of HIV/AIDS mass communication campaigns: have we made progress? J Health Commun. 2009;14:15–42.
49. Bertrand JT, O'Reilly K, Denison J, et al.. Systematic review of the effectiveness of mass communication programs to change HIV/AIDS-related behaviors in developing countries. Health Educ Res. 2006;21:567–597.
50. Vidanapathirana J, Abramson MJ, Forbes A, et al.. Mass media interventions for promoting HIV testing. Cochrane Database Syst Rev. 2005;CD004775.
51. Bertrand JT, Anhang R. The effectiveness of mass media in changing HIV/AIDS-related behaviour among young people in developing countries. World Health Organ Tech Rep Ser. 2006;938:205–241; discussion 317–41.
52. Yankah E, Aggleton P. Effects and effectiveness of life skills education for HIV prevention in young people. AIDS Educ Prev. 2008;20:465–485.
53. Lazarus JV, Sihvonen-Riemenschneider H, Laukamm-Josten U, et al.. Systematic review of interventions to prevent the spread of sexually transmitted infections, including HIV, among young people in Europe. Croat Med J. 2010;51:74–84.
54. Michielsen K, Chersich MF, Luchters S, et al.. Effectiveness of HIV prevention for youth in sub-Saharan Africa: systematic review and meta-analysis of randomized and nonrandomized trials. AIDS 2010;24:1193–1202.
55. Harrison A, Newell ML, Imrie J, et al.. HIV prevention for South African youth: which interventions work? A systematic review of current evidence. BMC Public Health. 2010;10:102.
56. Agbemenu K, Schlenk EA. An integrative review of comprehensive sex education for adolescent girls in Kenya. J Nurs Scholarship: An Official Publ Sigma Theta Tau Int Honor Soc Nurs/Sigma Theta Tau. 2011;43:54–63.
57. Napierala Mavedzenge SM, Doyle AM, Ross DA. HIV prevention in young people in sub-Saharan Africa: a systematic review. J Adolesc Health. 2011;49:568–586.
58. Tolli MV. Effectiveness of peer education interventions for HIV prevention, adolescent pregnancy prevention and sexual health promotion for young people: a systematic review of European studies. Health Educ Res. 2012;27:904–913.
59. Chin HB, Sipe TA, Elder R, et al.. The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive Services. Am J Prev Med. 2012;42:272–294.
60. Paul-Ebhohimhen VA, Poobalan A, van Teijlingen ER. A systematic review of school-based sexual health interventions to prevent STI/HIV in sub-Saharan Africa. BMC Public Health. 2008;8:4.
61. Robin L, Dittus P, Whitaker D, et al.. Behavioral interventions to reduce incidence of HIV, STD, and pregnancy among adolescents: a decade in review. J Adolesc Health. 2004;34:3–26.
62. Sales JM, Milhausen RR, Diclemente RJ. A decade in review: building on the experiences of past adolescent STI/HIV interventions to optimise future prevention efforts. Sex Transm Infect. 2006;82:431–436.
63. Gallant M, Maticka-Tyndale E. School-based HIV prevention programmes for African youth. Soc Sci Med. 2004;58:1337–1351.
64. Morrison-Beedy D, Nelson LE. HIV prevention interventions in adolescent girls: what is the state of the science? Worldviews Evid Based Nurs. 2004;1:165–175.
65. Kirby DB, Laris BA, Rolleri LA. Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world. J Adolesc Health. 2007;40:206–217.
66. Speizer IS, Magnani RJ, Colvin CE. The effectiveness of adolescent reproductive health interventions in developing countries: a review of the evidence. J Adolesc Health. 2003;33:324–348.
67. DiCenso A, Guyatt G, Willan A, et al.. Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. BMJ. 2002;324:1426.
68. Underhill K, Operario D, Montgomery P. Abstinence-only programs for HIV infection prevention in high-income countries. Cochrane Database Syst Rev. 2007;CD005421.
69. Kirby D, Obasi A, Laris BA. The effectiveness of sex education and HIV education interventions in schools in developing countries. World Health Organ Tech Rep Ser. 2006;938:103–150; discussion 317–341.
70. Zuurmond MA, Geary RS, Ross DA. The effectiveness of youth centers in increasing use of sexual and reproductive health services: a systematic review. Stud Fam Plann. 2012;43:239–254.
71. Blank L, Baxter SK, Payne N, et al.. Systematic review and narrative synthesis of the effectiveness of contraceptive service interventions for young people, delivered in educational settings. J Pediatr Adolesc Gynecol. 2010;23:341–351.
72. Mason-Jones AJ, Crisp C, Momberg M, et al.. A systematic review of the role of school-based healthcare in adolescent sexual, reproductive, and mental health. Syst Rev. 2012;1:49.
73. Pettifor A, MacPhail C, Nguyen N, et al.. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16:1729–1738.
74. Ranganathan M, Lagarde M. Promoting healthy behaviours and improving health outcomes in low and middle income countries: a review of the impact of conditional cash transfer programmes. Prev Med. 2012;55(suppl):S95–S105.
75. Braitstein P, Brinkhof MW, Dabis F, et al.. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–824.
76. Napierala Mavedzenge S, Baggaley R, Corbett EL. A review of self-testing for HIV: research and policy priorities in a new era of HIV prevention Clin Infect Dis. 2013. doi: 10.1093/cid/cit156.
77. Dick B, Ferguson J, Chandra-Mouli V, et al.. Review of the evidence for interventions to increase young people's use of health services in developing countries. World Health Organ Tech Rep Ser. 2006;938:151–204; discussion 317–341.
78. Maticka-Tyndale E, Brouillard-Coylea C. The effectiveness of community interventions targeting HIV and AIDS prevention at young people in developing countries. World Health Organ Tech Rep Ser. 2006;938:243–285; discussion 317–341.
79. WHO, Regional Office for South-East Asia, WHO, Regional Office for the Western Pacific, United Nations Office on Drugs and Crime, Regional Office for East Asia and the Pacific. Guidance on Testing and Counselling for HIV in Settings Attended by People Who Inject Drugs: Improving Access to Treatment, Care, and Prevention. Manila, Philippines: World Health Organization, Western Pacific Region; 2009.
80. Ross DA, Wight D, Dowsett G, et al.. The weight of evidence: a method for assessing the strength of evidence on the effectiveness of HIV prevention interventions among young people. World Health Organ Tech Rep Ser. 2006;938:79–102; discussion 317–341.
81. Kelly M, Swann C, Killoran A, et al.. Methodological Problems in Constructing the Evidence Base in Publich Health. London, United Kingdom: Health Development Agency; 2002.
82. Hayes RJ, Changalucha J, Ross DA, et al.. The MEMA kwa Vijana project: design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania. Contemp Clin Trials. 2005;26:430–442.
83. Obasi AI, Cleophas B, Ross DA, et al.. Rationale and design of the MEMA kwa Vijana adolescent sexual and reproductive health intervention in Mwanza Region, Tanzania. AIDS Care. 2006;18:311–322.
84. Doyle AM, Weiss HA, Maganja K, et al.. The long-term impact of the MEMA kwa Vijana adolescent sexual and reproductive health intervention: effect of dose and time since intervention exposure. PLoS One. 2011;6:e24866.
85. Cowan FM, Pascoe SJS, Langhaug LF, et al.. The Regai Dzive Shiri Project: a cluster randomised controlled trial to determine the effectiveness of a multi-component community-based HIV prevention intervention for rural youth in Zimbabwe–study design and baseline results. Trop Med Int Health. 2008;13:1235–1244.
86. Cowan FM, Pascoe S, Langhaug L, et al.. The Regai Dzive Shiri Project: results of a cluster randomised trial of a multi-component HIV prevention intervention for Zimbabwean youth. AIDS. 2010;24:2541–2552.
88. Stover J, Rosen J, Kasedde S, Idele P, McClure C. The impact and cost of the HIV/AIDS investment framework for adolescents. J Acquir Immune Defic Syndr. 2014;66(suppl 2):S170–S175.